Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Impl...(Neck Surgery. About Cochlear ...),Health

About Cochlear Implants

Cochlear implants are a proven medical option for children as young as 12 months old with profound hearing loss in both ears and for individuals who are two years or older with severe-to-profound hearing loss in both ears whom obtain little or no benefit from hearing aids. They are electronic devices, which bypass damaged hair cells in the inner ear, or cochlea, and stimulate the hearing nerve directly. Cochlear implants are designed to restore hearing, giving users the best possible hearing experience possible and are becoming the standard of care with approximately 400 institutions in the United States providing this technology.

About Cochlear

Cochlear is the world leader in implantable hearing solutions. Since launching the first multichannel cochlear implant system more than 25 years ago, Cochlear Limited has brought the miracle of sound to more than 180,000 individuals with hearing loss across the globe. Cochlear Americas markets number one selling products -- the Baha((R)) implantable bone-anchored hearing device and Nucleus cochlear implant technology. For more information about Cochlear Americas' products, call the Cochlear Hotline at 800/523-5798 (Voice) or visit www.cochlearamericas.com.

* Cochlear implants are a proven medical option for children as young as 12 months old with profound hearing loss in both ears and for children and adults who are two years or older with severe-to-profound hearing loss in both ears who have not demonstrated benefit from wearing a hearing aid.

(1) US patent 7, 184, 843. [On file] 2007 Feb 27

Nucleus is a registered trademark, and SmartSound, Set It and Go, and AutoPhone are trademarks of Cochlear Limited. Cochlear and the elliptical logo are trademarks of Cochle
'/>"/>